BLU - BELLUS Health Inc.

Historical Data of BELLUS Health Inc.(BLU), BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatm

photo-url-https://financialmodelingprep.com/image-stock/BLU.png

BELLUS Health Inc.

BLU

NASDAQ

Inactive Equity

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.

14.75 USD

0.005 (0.03391%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Historical Prices

From:

To:

We are unable to load the chart at this time.

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.